Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Novel approaches in anaplastic thyroid cancer therapy.

Hsu KT, Yu XM, Audhya AW, Jaume JC, Lloyd RV, Miyamoto S, Prolla TA, Chen H.

Oncologist. 2014 Nov;19(11):1148-55. doi: 10.1634/theoncologist.2014-0182. Epub 2014 Sep 26. Review.

2.

The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.

Weinlander E, Somnay Y, Harrison AD, Wang C, Cheng YQ, Jaskula-Sztul R, Yu XM, Chen H.

J Surg Res. 2014 Jul;190(1):191-7. doi: 10.1016/j.jss.2014.02.042. Epub 2014 Feb 28.

3.

Hesperetin activates the Notch1 signaling cascade, causes apoptosis, and induces cellular differentiation in anaplastic thyroid cancer.

Patel PN, Yu XM, Jaskula-Sztul R, Chen H.

Ann Surg Oncol. 2014 Dec;21 Suppl 4:S497-504. doi: 10.1245/s10434-013-3459-7. Epub 2014 Jan 14.

4.

Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival.

Shepet K, Alhefdhi A, Lai N, Mazeh H, Sippel R, Chen H.

Ann Surg Oncol. 2013 May;20(5):1451-5. doi: 10.1245/s10434-012-2757-9. Epub 2012 Nov 29.

5.

Antiproliferative effect of chrysin on anaplastic thyroid cancer.

Phan T, Yu XM, Kunnimalaiyaan M, Chen H.

J Surg Res. 2011 Sep;170(1):84-8. doi: 10.1016/j.jss.2011.03.064. Epub 2011 Apr 20.

6.

Multi-targeted approach in the treatment of thyroid cancer.

Zarebczan B, Chen H.

Minerva Chir. 2010 Feb;65(1):59-69. Review.

7.
Items per page

Supplemental Content

Write to the Help Desk